The Role of Somatostatin Analogues in the Control of Diarrhea and Flushing as Markers of Carcinoid Syndrome: A Systematic Review and Meta-Analysis.

Krystallenia I Alexandraki Anna Angelousi Eleftherios ChatzellisAlexandra ChrisoulidouNikolaos KalogerisGeorgios KanakisChristos SavvidisDimitra VassiliadiAriadni Spyroglou Georgios Kostopoulos Vyron MarkussisKonstantinos ToulisStylianos TsagarakisGregory A Kaltsas

Published in: Journal of personalized medicine (2023)

We estimate there is a 67-68% overall reduction in symptoms of CS associated with SSA treatment. However, significant heterogeneity was detected, possibly revealing differences in the disease course, in management and in outcome definition.

Keyphrases

single cell
molecular docking
sleep quality
neuroendocrine tumors
physical activity
replacement therapy